Oncolytics lung cancer drug meets main goal in mid-stage trial

(Reuters) - Oncolytics Biotech Inc said the first part of a mid-stage trial of its lung cancer drug met the main goal of showing patient response.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/Avx1yTvnoTs/us-oncolytics-study-cancerdrug-idUSBRE88C0LQ20120913

where to take phlebotomy classes certified programs rop phlebotomy classes